The Pfizer New Haven PCRU has been home to hundreds of clinical trials for potential new medicines.

And when the pandemic hit, the PCRU was tapped to test a potential new medicine to help treat COVID-19.

The stakes were high, and the clock was ticking, but the dedicated professionals at the PCRU, along with hundreds of study participants, stepped up to the challenge.

Together, they made an unprecedented team effort against an unprecedented global health crisis.

Together, they helped make the next breakthrough possible.

Below, some of the many Pfizer CRU colleagues share first-hand details about their experiences during the trial and their jobs on the front lines of clinical research.